LFCR R&D to Revenue
Lifecore Biomedical Inc · R&D to Revenue
LFCR R&D to Revenue
Latest reported6.57%period ending
LFCR FY R&D/Revenue (152.00% → 6.57%)
Latest values, visible window
High-resolution chart · PNG
LFCR r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 6.5678% | |
| 6.4082% | |
| 6.6856% | |
| 8.4595% | |
| 7.045% | |
| 6.6261% | |
| 4.7368% | |
| 2.0565% | |
| 2.4417% | |
| 1.7798% | |
| 1.3358% | |
| 1.2959% | |
| 1.5109% | |
| 2.1041% | |
| 3.031% | |
| 3.3517% | |
| 1.8306% | |
| 1.5534% | |
| 1.3629% | |
| 1.4603% | |
| 1.3115% | |
| 1.2391% | |
| 1.9428% | |
| 0% | |
| 2.0005% | |
| 1.7131% | |
| 2.241% | |
| 16.3842% | |
| 17.0149% | |
| 80% | |
| 152% |